Evidence map›Paper›PMID 41342961›Full record

ReviewDiscover oncology2025

Surgical intervention strategies for tumor microenvironment (TME) associated therapeutic resistance.

Dong Chen, Hanyu Wang, Xu Che

Abstract readReview
In one paragraph

Review in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dong ChenNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital,, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China.
Hanyu WangNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital,, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China.
Xu CheNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital,, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China. gandan-chendong@cicams-sz.org.cn.

Funding

Sanming Project of Medicine in Shenzen Municipality SZSM202011010
6 · The paper itself

Abstract

The tumor microenvironment (TME) drives therapeutic resistance through immunosuppression, stromal remodeling, and metabolic reprogramming, which pose a major challenge in solid tumor treatment. While surgery remains a cornerstone for tumor eradication, perioperative inflammatory responses and ischemia-reperfusion injuries may exacerbate TME deterioration. However, surgery also offers a strategic opportunity for TME modulation. This narrative review analyzes TME components and resistance mechanisms, proposing a multi-stage intervention framework: preoperative TME reshaping, intraoperative precision resection with local therapy, and postoperative dynamic monitoring. We further explore a multidisciplinary whole-course management model, integrating cutting-edge technologies such as radiomics and single-cell sequencing. By bridging basic research with clinical translation, this review aims to guide surgeons in transitioning from tumor resection to TME precision regulation, with a focus on perioperative multi-stage interventions.

Indexed as

Multidisciplinary collaborationSurgical interventionTherapeutic resistanceTumor microenvironment

Identifiers

PMID41342961
PMCPMC12770208

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.